Forskolin induction of late-LTP and up-regulation of 5' TOP mRNAs translation via mTOR, ERK, and PI3K in hippocampal pyramidal cells

J Neurochem. 2008 Aug;106(3):1160-74. doi: 10.1111/j.1471-4159.2008.05470.x. Epub 2008 May 9.

Abstract

The late phase of long-term potentiation (LTP) requires activation of the mammalian target of rapamycin (mTOR) pathway and synthesis of new proteins. mTOR regulates protein synthesis via phosphorylation of 4E-binding proteins (4E-BPs) and S6K, and via selective up-regulation of 5' terminal oligopyrimidine (5' TOP) mRNAs that encode components of the translational machinery. In this study, we explored the regulation of 5' TOP mRNAs during late-LTP (L-LTP). Synaptic plasticity was studied at Schaffer collateral--CA1 pyramidal cell synapses in rat organotypic hippocampal slices. Forskolin, an adenylate cyclase activator, induced L-LTP in organotypic slices that was mTOR-dependent. To determine if 5' TOP mRNAs are specifically up-regulated during L-LTP, we generated a 5' TOP-myr-dYFP reporter to selectively monitor 5' TOP translation. Confocal imaging experiments in cultured slices revealed an increase in somatic and dendritic fluorescence after forskolin treatment. This up-regulation was dependent on an intact TOP sequence and was mTOR, extracellular signal-regulated kinase (ERK), and phosphatidylinositol 3-kinase (PI3K)-dependent. Our findings indicate that forskolin induces L-LTP in hippocampal neurons and up-regulates 5' TOP mRNAs translation via mTOR, suggesting that up-regulation of the translational machinery is a candidate mechanism for the stabilization of LTP.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colforsin / pharmacology*
  • Extracellular Signal-Regulated MAP Kinases / genetics
  • Extracellular Signal-Regulated MAP Kinases / physiology*
  • Hippocampus / drug effects
  • Hippocampus / physiology
  • Humans
  • Long-Term Potentiation / drug effects
  • Long-Term Potentiation / physiology*
  • Male
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / physiology*
  • Protein Biosynthesis / drug effects
  • Protein Biosynthesis / physiology
  • Protein Kinases / biosynthesis
  • Protein Kinases / genetics
  • Protein Kinases / physiology*
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / enzymology*
  • Pyramidal Cells / physiology
  • RNA 5' Terminal Oligopyrimidine Sequence / drug effects
  • RNA 5' Terminal Oligopyrimidine Sequence / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • TOR Serine-Threonine Kinases
  • Up-Regulation / drug effects
  • Up-Regulation / physiology

Substances

  • Colforsin
  • Protein Kinases
  • MTOR protein, human
  • mTOR protein, rat
  • TOR Serine-Threonine Kinases
  • Extracellular Signal-Regulated MAP Kinases

Grants and funding